Ledger.Open graph →
SEC Form D · filed April 10, 2017

Cirius Therapeutics, Inc

Offering
$40.5M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KALAMAZOO, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Robert Baltera · Kalamazoo, MIExec · DirectorDavid Van Andel · Kalamazoo, MIDirectorHoward Dittrich · Cleveland, OHExecDaniel Estes · Kalamazoo, MIDirectorMichael Jandernoa · Kalamazoo, MIDirectorRobert Zerbe · Kalamazoo, MIDirectorBrian Farmer · LA JOLLA, CAExecNilesh Kumar · Menlo Park, CADirectorBrian Farmer · LA JOLLA, CAExecNilesh Kumar · Menlo Park, CADirectorRobert Baltera · San Diego, CAExec · DirectorDavid Van Andel · Grand Rapids, MIDirectorHoward Dittrich · LA JOLLA, CAExecDaniel Estes · Kalamazoo, MIDirectorMichael Jandernoa · Kalamazoo, MIDirectorRobert Zerbe · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗